171 related articles for article (PubMed ID: 20680615)
1. Characterization of currently marketed heparin products: key tests for quality assurance.
Keire DA; Ye H; Trehy ML; Ye W; Kolinski RE; Westenberger BJ; Buhse LF; Nasr M; Al-Hakim A
Anal Bioanal Chem; 2011 Jan; 399(2):581-91. PubMed ID: 20680615
[TBL] [Abstract][Full Text] [Related]
2. Characterization of currently marketed heparin products: key tests for LMWH quality assurance.
Ye H; Toby TK; Sommers CD; Ghasriani H; Trehy ML; Ye W; Kolinski RE; Buhse LF; Al-Hakim A; Keire DA
J Pharm Biomed Anal; 2013 Nov; 85():99-107. PubMed ID: 23917037
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparin.
Mans DJ; Ye H; Dunn JD; Kolinski RE; Long DS; Phatak NL; Ghasriani H; Buhse LF; Kauffman JF; Keire DA
Anal Biochem; 2015 Dec; 490():52-4. PubMed ID: 26278168
[TBL] [Abstract][Full Text] [Related]
4. Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches.
Keire DA; Mans DJ; Ye H; Kolinski RE; Buhse LF
J Pharm Biomed Anal; 2010 Sep; 52(5):656-64. PubMed ID: 20233649
[TBL] [Abstract][Full Text] [Related]
5. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
[TBL] [Abstract][Full Text] [Related]
6. Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples.
Alban S; Lühn S; Schiemann S; Beyer T; Norwig J; Schilling C; Rädler O; Wolf B; Matz M; Baumann K; Holzgrabe U
Anal Bioanal Chem; 2011 Jan; 399(2):605-20. PubMed ID: 20824424
[TBL] [Abstract][Full Text] [Related]
7. Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.
Keire DA; Trehy ML; Reepmeyer JC; Kolinski RE; Ye W; Dunn J; Westenberger BJ; Buhse LF
J Pharm Biomed Anal; 2010 Mar; 51(4):921-6. PubMed ID: 19959313
[TBL] [Abstract][Full Text] [Related]
8. Analysis and characterization of heparin impurities.
Beni S; Limtiaco JF; Larive CK
Anal Bioanal Chem; 2011 Jan; 399(2):527-39. PubMed ID: 20814668
[TBL] [Abstract][Full Text] [Related]
9. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
[TBL] [Abstract][Full Text] [Related]
10. Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins.
Alban S; Lühn S; Schiemann S
Anal Bioanal Chem; 2011 Jan; 399(2):681-90. PubMed ID: 20953779
[TBL] [Abstract][Full Text] [Related]
11. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U
Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266
[TBL] [Abstract][Full Text] [Related]
12. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.
Somsen GW; Tak YH; Toraño JS; Jongen PM; de Jong GJ
J Chromatogr A; 2009 May; 1216(18):4107-12. PubMed ID: 19272607
[TBL] [Abstract][Full Text] [Related]
13. Orthogonal analytical approaches to detect potential contaminants in heparin.
Guerrini M; Zhang Z; Shriver Z; Naggi A; Masuko S; Langer R; Casu B; Linhardt RJ; Torri G; Sasisekharan R
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):16956-61. PubMed ID: 19805108
[TBL] [Abstract][Full Text] [Related]
14. Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography.
Hashii N; Kawasaki N; Itoh S; Qin Y; Fujita N; Hattori T; Miyata K; Bando A; Sekimoto Y; Hama T; Kashimura M; Tatsumi M; Mabuchi K; Namekawa H; Sakai T; Hirose M; Dobashi S; Shimahashi H; Koyama S; Herr SO; Kawai K; Yoden H; Yamaguchi T
Biologicals; 2010 Sep; 38(5):539-43. PubMed ID: 20452241
[TBL] [Abstract][Full Text] [Related]
15. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
[TBL] [Abstract][Full Text] [Related]
16. Heparin sodium compliance to the new proposed USP monograph: elucidation of a minor structural modification responsible for a process dependent 2.10 ppm NMR signal.
Mourier PA; Guichard OY; Herman F; Viskov C
J Pharm Biomed Anal; 2011 Jan; 54(2):337-44. PubMed ID: 20934294
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
[TBL] [Abstract][Full Text] [Related]
18. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
Gray A; Litinas E; Jeske W; Fareed J; Hoppensteadt D
Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630
[TBL] [Abstract][Full Text] [Related]
19. Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.
Zhang Z; Li B; Suwan J; Zhang F; Wang Z; Liu H; Mulloy B; Linhardt RJ
J Pharm Sci; 2009 Nov; 98(11):4017-26. PubMed ID: 19642166
[TBL] [Abstract][Full Text] [Related]
20. NMR of heparin API: investigation of unidentified signals in the USP-specified range of 2.12-3.00 ppm.
Lee SE; Chess EK; Rabinow B; Ray GJ; Szabo CM; Melnick B; Miller RL; Nair LM; Moore EG
Anal Bioanal Chem; 2011 Jan; 399(2):651-62. PubMed ID: 20949261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
